Breaking News Instant updates and real-time market news.

STMP

Stamps.com

$76.12

0.55 (0.73%)

16:54
10/21/19
10/21
16:54
10/21/19
16:54

Stamps.com up 20% at $91.50/shr after entering logistics services deal with UPS

  • 07

    Nov

STMP Stamps.com
$76.12

0.55 (0.73%)

09/04/19
ROTH
09/04/19
UPGRADE
Target $52
ROTH
Neutral
Stamps.com upgraded to Neutral from Sell at Roth Capital
Roth Capital analyst Darren Aftahi upgraded Stamps.com to Neutral from Sell and raised his price target for the shares to $52 from $32.
09/04/19
ROTH
09/04/19
UPGRADE
Target $52
ROTH
Neutral
Roth Capital upgrades Stamps.com to Neutral after favorable USPS checks
Roth Capital analyst Darren Aftahi upgraded Stamps.com to Neutral from Sell and raised his price target for the shares to $52 from $32. The stock closed Tuesday at $64.20. Following a round of channel checks with United State Postal Service ecosystem participants, the analyst believes more favorable rate cards for resellers could continue into 2020. As a result, he has a slightly more favorable view of Stamps.com's 2020, with raised revenue and adjusted EBITDA estimates. His upgrade to Neutral reflects his belief that Stamps.com's risk profile "has been mitigated somewhat."
09/04/19
09/04/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Campbell Soup (CPB) upgraded to Neutral from Underweight at Piper Jaffray with analyst Michael Lavery saying better focus and reinvestment in key brands can drive long-term benefits for Campbell. 2. Intercept (ICPT) upgraded to Buy from Neutral at Citi with analyst Joel Beatty saying the stock is down 45% since the Phase 3 nonalcoholic steatohepatitis Regnerate results for Intercept's obeticholic acid were announced in February, despite the data being positive. 3. Brunswick (BC) upgraded to Buy from Hold at Jefferies with analyst Randal Konik saying with expectations recalibrated post the Q2 results, Brunswick's risk/reward set-up is at its most favorable in four years. 4. Stamps.com (STMP) upgraded to Neutral from Sell at Roth Capital with analyst Darren Aftahi saying after a round of channel checks with United State Postal Service ecosystem participants, the analyst believes more favorable rate cards for resellers could continue into 2020. As a result, he has a slightly more favorable view of Stamps.com's 2020, with raised revenue and adjusted EBITDA estimates. 5. Activision Blizzard (ATVI) upgraded to Outperform from Market Perform at BMO Capital with analyst Gerrick Johnson saying he has a stronger conviction that the company's restructuring efforts and its investment in core franchise titles like Call of Duty and World of Warcraft will yield improved financial performance. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/04/19
RILY
10/04/19
NO CHANGE
Target $62.5
RILY
Buy
Stamps.com price target raised to $62.50 from $50 at B. Riley FBR
B. Riley FBR analyst Zach Cummins raised his price target for Stamps.com to $62.50 from $50 ahead of the company's Q3 results and reiterates a Neutral rating on the shares. The "seemingly more positive tone" in negotiations with the United States Postal Service could potentially lead to an extension of the current negotiated service agreements margins for Stamps.com's remaining reseller partner, Cummins tells investors in a research note. As such, he modestly increasing his estimates for this year and next. However, the analyst says that while developments with the reseller program have improved since Q1, he remains cautious around the forward numbers for Stamps.com, believing the USPS will meaningfully reduce margins for resellers in fiscal 2020 and 2021.

TODAY'S FREE FLY STORIES

SNCR

Synchronoss

$4.01

-0.26 (-6.09%)

, T

AT&T

$39.37

(0.00%)

08:16
11/12/19
11/12
08:16
11/12/19
08:16
Hot Stocks
Synchronoss collaborates with CCMI joint venture »

Synchronoss Technologies…

SNCR

Synchronoss

$4.01

-0.26 (-6.09%)

T

AT&T

$39.37

(0.00%)

S

Sprint

$5.91

-0.2 (-3.27%)

TMUS

T-Mobile

$79.64

-1.28 (-1.58%)

VZ

Verizon

$59.61

0.27 (0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 18

    Nov

  • 19

    Nov

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 10

    Dec

  • 29

    Jan

  • 30

    Jan

GILD

Gilead

$64.66

-0.68 (-1.04%)

08:15
11/12/19
11/12
08:15
11/12/19
08:15
Initiation
Gilead initiated  »

Gilead initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

AFG

American Financial Group

$109.84

-0.75 (-0.68%)

08:14
11/12/19
11/12
08:14
11/12/19
08:14
Conference/Events
American Financial Group management to meet with Sandler ONeill »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

SCPH

scPharmaceuticals

$5.26

0.11 (2.14%)

08:13
11/12/19
11/12
08:13
11/12/19
08:13
Hot Stocks
scPharmaceuticals expects 2019 cash, cash equivalents $65M-$70M »

Based on its current…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCPH

scPharmaceuticals

$5.26

0.11 (2.14%)

08:12
11/12/19
11/12
08:12
11/12/19
08:12
Earnings
scPharmaceuticals reports Q3 EPS (31c), consensus (45c) »

"We continue to make…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$16.90

-0.58 (-3.32%)

08:12
11/12/19
11/12
08:12
11/12/19
08:12
Hot Stocks
Amarin jumps as FDA posts documents for Vascepa advisory committee meeting »

Shares of Amarin (AMRN)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 28

    Dec

CBMG

Cellular Biomedicine

$17.86

0.11 (0.62%)

08:12
11/12/19
11/12
08:12
11/12/19
08:12
Downgrade
Cellular Biomedicine rating change  »

Cellular Biomedicine…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VCNX

Vaccinex

$5.05

0.19 (3.91%)

08:11
11/12/19
11/12
08:11
11/12/19
08:11
Earnings
Vaccinex reports Q3 revenue $404,000, consensus 30,000 »

"The highlight of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RKDA

Arcadia Biosciences

$4.08

-0.015 (-0.37%)

, BIOX

Bioceres

$5.70

-0.2 (-3.39%)

08:11
11/12/19
11/12
08:11
11/12/19
08:11
Hot Stocks
Verdeca receives approval of HB4 drought and herbicide tolerant soybeans »

Verdeca, a joint venture…

RKDA

Arcadia Biosciences

$4.08

-0.015 (-0.37%)

BIOX

Bioceres

$5.70

-0.2 (-3.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NH

NantHealth

$0.70

0.008 (1.16%)

08:11
11/12/19
11/12
08:11
11/12/19
08:11
Hot Stocks
NantHealth reports FDA marketing authorization of Omics Core »

NantHealth reported FDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$16.90

-0.58 (-3.32%)

08:11
11/12/19
11/12
08:11
11/12/19
08:11
Hot Stocks
Amarin soars after FDA posts briefing docs ahead of Nov. 14 panel »

Shares of Amarin are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 28

    Dec

SWTX

SpringsWorks Therapeutics

$18.42

-0.1 (-0.54%)

08:10
11/12/19
11/12
08:10
11/12/19
08:10
Earnings
SpringsWorks Therapeutics reports Q3 EPS ($1.77), consensus (47c) »

"The third quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLNE

Clean Energy

$2.23

-0.01 (-0.45%)

08:09
11/12/19
11/12
08:09
11/12/19
08:09
Earnings
Clean Energy reports Q3 EPS (2c), consensus (2c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

HON

Honeywell

$180.73

-0.48 (-0.26%)

08:09
11/12/19
11/12
08:09
11/12/19
08:09
Hot Stocks
Honeywell Process Solutions selected by Kuwait Integrated Petroleum Industries »

Honeywell announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLRB

Cellectar Biosciences

$1.30

-0.095 (-6.81%)

08:09
11/12/19
11/12
08:09
11/12/19
08:09
Hot Stocks
Cellectar Biosciences expects cash to fund operations into 1Q21 »

As of September 30, 2019,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLRB

Cellectar Biosciences

$1.30

-0.095 (-6.81%)

08:08
11/12/19
11/12
08:08
11/12/19
08:08
Earnings
Cellectar Biosciences reports Q3 EPS (42c), consensus (38c) »

"We continue to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBRX

Moleculin Biotech

$1.05

-0.02 (-1.87%)

08:08
11/12/19
11/12
08:08
11/12/19
08:08
Hot Stocks
Moleculin Biotech receives FDA approval for IND of WP1066 »

Moleculin Biotech…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

LOGC

LogicBio Therapeutics

$9.49

0.09 (0.96%)

08:07
11/12/19
11/12
08:07
11/12/19
08:07
Hot Stocks
LogicBio Therapeutics expects cash to fund operations into 2021 »

Cash, cash equivalents…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOGC

LogicBio Therapeutics

$9.49

0.09 (0.96%)

08:07
11/12/19
11/12
08:07
11/12/19
08:07
Earnings
LogicBio Therapeutics reports Q3 EPS (48c), consensus (46c) »

"This has been a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$16.90

-0.58 (-3.32%)

08:06
11/12/19
11/12
08:06
11/12/19
08:06
Hot Stocks
Breaking Hot Stocks news story on Amarin »

Amarin jumps 7% to $18.13…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 28

    Dec

MPAA

Motorcar Parts

$19.96

-0.66 (-3.20%)

08:06
11/12/19
11/12
08:06
11/12/19
08:06
Earnings
Motorcar Parts reports Q2 adj. EPS 68c, consensus 41c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

FATE

Fate Therapeutics

$14.49

-0.09 (-0.62%)

08:06
11/12/19
11/12
08:06
11/12/19
08:06
Initiation
Fate Therapeutics initiated  »

Fate Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LM

Legg Mason

$38.33

0.17 (0.45%)

08:06
11/12/19
11/12
08:06
11/12/19
08:06
Hot Stocks
Legg Mason reports AUM of $791.0B as of October 31 »

Legg Mason reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBS

CBS

$39.21

1.09 (2.86%)

, VIA

Viacom

$26.40

0.87 (3.41%)

08:06
11/12/19
11/12
08:06
11/12/19
08:06
Hot Stocks
CBS, Viacom merger expected to close in early December »

On August 13, CBS (CBS)…

CBS

CBS

$39.21

1.09 (2.86%)

VIA

Viacom

$26.40

0.87 (3.41%)

VIAB

Viacom

$23.46

0.71 (3.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 14

    Nov

  • 14

    Nov

  • 09

    Dec

08:05
11/12/19
11/12
08:05
11/12/19
08:05
Conference/Events
Craig-Hallum to hold a conference »

10th Annual Craig-Hallum…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.